Study of Oglemilast for the Treatment of Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2006

Conditions

Asthma

Interventions

DRUG

Oglemilast

Oglemilast, 15mg oral administration, once per day and then dose-matched placebo

DRUG

Placebo then Oglemilast

Dose-matched placebo and then Oglemilast, 15mg, oral administration, once per day.

Trial Locations (1)

Forest Investigative Site, Los Angeles